CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- 8-K Event Other events
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Director bought 24,500 shares at $2.27 ($55,615)
- 4 Open-market buy Director bought 31,083 shares at $2.27 ($70,558)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.03 ($40,600)
- 10-Q Report Quarterly Report
- 4 Other acquisition COO & CFO acquired 1,867 shares (other)
- 8-K Event Material agreement
- 4 Open-market buy Director bought 5,799 shares at $2.12 ($12,294)
- 4 Open-market buy Director bought 10,000 shares at $1.84 ($18,400)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $1.82 ($36,400)
- 4 Open-market buy Director bought 10,000 shares at $2.71 ($27,100)
- 10-Q Report Quarterly Report
- 4 Open-market buy Director bought 10,000 shares at $3.53 ($35,300)
- 4 Open-market buy Director bought 5,000 shares at $3.32 ($16,600)
- 4 Open-market buy Director bought 7,400 shares at $3.22 ($23,828)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $2.99 ($59,800)
- 10-K/A Report 10-K/A
- 424B3 Offering Prospectus
- 10-K Report Annual Report
Page 12 of 50 · 983 filings